FDA Rejects Qtrypta NDA for Acute Treatment of Migraine By Brian Park, PharmD Publish Date October 22, 2020
Osimertinib Gets Priority Review for Early-Stage EGFR-Mutated NSCLC By Brian Park, PharmD Publish Date October 21, 2020
NIH: Immune Modulators to Be Investigated for COVID-19 By Brian Park, PharmD Publish Date October 19, 2020
Ibrexafungerp NDA for Vulvovaginal Candidiasis Submitted for Review By Brian Park, PharmD Publish Date October 16, 2020
FDA Rejects IV Tramadol Over Potential Safety Concern By Brian Park, PharmD Publish Date October 14, 2020
FDA Committees Vote on Novel Therapy for Schizophrenia, Bipolar I Disorder By Diana Ernst, RPh Publish Date October 13, 2020
Clinically Meaningful Improvements With Ozanimod in UC Trial By Diana Ernst, RPh Publish Date October 13, 2020
Palbociclib Misses Primary End Point in Early Breast Cancer Trial By Brian Park, PharmD Publish Date October 13, 2020
Trial Evaluating Anti-SARS-CoV-2 Hyperimmune Globulin Begins By Brian Park, PharmD Publish Date October 13, 2020
Idiopathic Hypersomnia Study Evaluating Xywav Meets End Points By Brian Park, PharmD Publish Date October 9, 2020
Antibody Therapy VIR-7831 Enters Phase 3 for Outpatient COVID-19 Treatment By Brian Park, PharmD Publish Date October 9, 2020
Mixed Results for Omecamtiv Mecarbil in Heart Failure Study By Diana Ernst, RPh Publish Date October 8, 2020
Combination Antibody Therapy Reduces Viral Load, COVID-19 Hospitalizations By Diana Ernst, RPh Publish Date October 8, 2020
Emergency Use Authorization Guidance Issued for COVID-19 Vaccines By Brian Park, PharmD Publish Date October 7, 2020
Investigational Gene Therapy for Phenylketonuria Gets Fast Tracked By Brian Park, PharmD Publish Date October 6, 2020
FDA: More Data on Remestemcel-L for Graft Versus Host Disease Needed By Brian Park, PharmD Publish Date October 6, 2020
Dapagliflozin Gets Breakthrough Therapy Status for CKD Indication By Brian Park, PharmD Publish Date October 5, 2020
Investigational Gene Therapy Fast Tracked for Duchenne Muscular Dystrophy By Brian Park, PharmD Publish Date October 5, 2020
Moderna’s COVID-19 Vaccine Candidate Elicits Immune Response in Older Adults By Brian Park, PharmD Publish Date September 30, 2020
